Sir Menelas Pangalos on R&D at AstraZeneca, covid vaccines and the new Cambridge Discovery Centre
placeholder
EVice President of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board, AstraZeneca
Search every verified Menelas Pangalos interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a 2019 interview with CEO Pascal Soriot, Mene Pangalos discussed his career at AstraZeneca, which began in 2010. He described the company's R&D transformation as placing it "amongst the very best organizations" and said the pipeline was "delivering." Pangalos attributed the company's progress to "high-caliber science," data-driven decision-making, and a focus on unmet medical need. He also highlighted the importance of collaboration, citing the move to Cambridge as a way to make AstraZeneca "more attractive, more porous and more collaborative" within the local life sciences ecosystem. Pangalos identified data science and artificial intelligence as areas of growing impact across R&D, from molecule design to clinical trial site selection. He advised young scientists to "love what you do," surround themselves with "great people," and remain open to new ideas. The interview followed Pangalos receiving an honor from the Queen, which he called "truly humbling" and a testament to his colleagues and partners.
Our continued scientific advancements are driven by our commitment to help patients worldwide. See our full Q3 2021 financial highlights: https://www.astrazeneca.com/media-cen... ------------------------------------------------------------ Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: Twitter: / astrazeneca LinkedIn: / astrazeneca Instagram: / astrazeneca Facebook: / astrazeneca
Turning science into medicine: R&D at AstraZeneca including the fight against COVID-19 Sir Mene Pangalos, Executive Vice President of BioPharmaceuticals Research and Development at AstraZeneca, is interviewed by Professor Stelios Kavadias, Margaret Thatcher Professor of Enterprise Studies in Innovation & Growth and Co-Director of the Entrepreneurship Centre, about the incredible journey to creating a COVID-19 vaccine, alongside other major research. Pangalos reflects on how AstraZeneca has changed as biopharmaceutical company over the last decade, and its further transformation during the pan…
Welcome Speaker: Stephen McLaughlin, MRC Laboratory of Molecular Biology, UK. Opening Remarks Speaker: Sir Mene Pangalos, EVP Biopharmaceuticals R&D, AstraZeneca The Next Generation Biophysics Symposium 2020 was an informal one-day meeting organised by Astra Zeneca, MRC LMB and Imperial College London examining the application of cutting-edge biophysical techniques in complex biological settings. Bringing together scientists in both academia and industry for stimulating talks and discussions how these new and emerging technologies may be able to address challenging questions in the future.…
GapSummit 2020 Keynote Q&A with Sir Mene Pangalos, Sir Mene Pangalos, Executive Vice President BioPharmaceuticals R&D, AstraZeneca, hosted by Rebecca Harris, Vice President GapSummit 2020. GapSummit is the flagship event of Global Biotech Revolution (GBR), a student-led not-for-profit with the mission to inspire young people and support the next generation of leaders to ensure sustainability and growth of the biotechnology industry. Find out more here: globalbiotechrevolution.com
GapSummit 2020 Keynote titled 'Turning Science into Medicine' by Sir Mene Pangalos, Executive Vice President BioPharmaceuticals R&D, AstraZeneca. GapSummit is the flagship event of Global Biotech Revolution (GBR), a student-led not-for-profit with the mission to inspire young people and support the next generation of leaders to ensure sustainability and growth of the biotechnology industry. Find out more here: globalbiotechrevolution.com
Join Sir Mene N Pangalos, EVP & President BioPharmaceuticals R&D, AstraZeneca, in conversation with Professor Tom Otis ...
Our CEO Pascal Soriot interviews Mene Pangalos, Executive Vice President of BioPharmaceuticals Reasearch and Development, about his scientific highlights, his values, the talented teams he has worked with and the importance of never being complacent and seeking the truth. Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: Twitter: / astrazeneca LinkedIn: / astrazeneca Instagram: / astrazeneca Facebook: / astrazeneca
"Science has the power to change the world for the better. In our industry, we are lucky that we are sometimes able to translate our science into medicines that can transform the lives of millions of patients." Mene Pangalos, Executive Vice President of BioPharmaceuticals Research and Development, has been awarded a knighthood by Her Majesty The Queen in the New Year 2020 Honours List in recognition of his services to UK science. Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: Twitter: / astrazeneca LinkedIn: / astrazeneca Instag…
In this first of a new series, in conversation with the pharmaceutical industry's pioneers of innovation, I was able to discuss the remarkable transformation seen at AstraZeneca, who this year topped the Pharmaceutical Innovation Index (ideapharma.com/pii ). There's a lot of really fascinating insight here, but I'd like you to take away the very human approach, and the very humble approach, taken by the senior leadership at AstraZeneca towards the pursuit of improvement 0:30 What does AstraZeneca mean by ‘innovative medicines’? 02:00 Inward vs external focus 03:10 What changed when Pascal Sor…
Keynote lecture by Mene Pangalos (Astra Zeneca, UK) at Target Validation Using Genomics and Informatics (8-10 December ...
London Innovation Summit 2014 Medical Technologies Dr Mene Pangalos, Executive Vice President, Head of Innovative Medicines and Early Development, AstraZeneca Which medical technologies will yield the greatest benefits What benefits can we expect from MedCity London Immunotherapy #AstraZeneca #MedTech
Sign in to search the full transcript archive, filter by topic, and access every quote from Menelas Pangalos.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans